Tag: pharmaceutical merger
Top News
Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026
MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.
- Our Sponsors Ad -